本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cytokinetics

62.79
-0.1200-0.19%
盘前:62.790.00000.00%04:39 EDT
成交量:125.41万
成交额:7,885.77万
市值:87.29亿
市盈率:-8.74
高:63.50
开:62.48
低:62.13
收:62.91
52周最高:88.31
52周最低:54.30
股本:1.39亿
流通股本:1.38亿
量比:0.50
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-7.1827
每股收益(LYR):-6.5400
净资产收益率:-572.15%
总资产收益率:-28.09%
市净率:-50.32
市盈率(LYR):-9.60

数据加载中...

2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

重要事件披露

Form 8-K - Current report
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

重要事件披露

Form 8-K - Current report
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report